Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

KEPPRA vs KETOTIFEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

KEPPRA vs KETOTIFEN: Safety Overview

Metric KEPPRA KETOTIFEN
Total FAERS Reports 606 5,209
Deaths Reported 37 9
Death Rate 6.1% 0.2%
Hospitalizations 266 99
Average Patient Age 42.5 yrs 57.8 yrs
% Female Patients N/A 73.1%
FDA Approval Date N/A Dec 1, 2006
Manufacturer N/A CVS Pharmacy
Route N/A OPHTHALMIC
Marketing Status N/A Discontinued